# MBX Biosciences, Inc. Common Stock (MBX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MBX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -60.61M | $ -44.17M | $ 3.34M | $ 409.54M |
| 2025 | $ 0 | $ -89.05M | $ -83.84M | $ 596.0K | $ 369.22M |
| 2024 | $ 0 | $ -65.08M | $ -58.39M | $ 171.0K | $ 257.44M |
| 2023 | $ 0 | $ -35.21M | $ -34.72M | $ 324.0K | $ -72.47M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 18.08 |

## Other views

- [Metrics](https://sponda.capital/en/MBX.md)
- [Charts](https://sponda.capital/en/MBX/charts.md)
- [Compare](https://sponda.capital/en/MBX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.